About Biofidelity
Biofidelity is a company based in Cambridge (United Kingdom) founded in 2002 by Barney Balmforth and Cameron Frayling.. Biofidelity has raised $59.91 million across 4 funding rounds from investors including Agilent, Octopus Ventures and BlueYard Capital. The company has 28 employees as of December 31, 2024. Biofidelity offers products and services including Aspyre®, Aspyre® Lung Reagents, and Enspyre®. Biofidelity operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Cambridge, United Kingdom
- Employees 28 as on 31 Dec, 2024
- Founders Barney Balmforth, Cameron Frayling
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biofidelity Ltd
- Date of Incorporation 15 Feb, 2019
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$59.91 M (USD)
in 4 rounds
-
Latest Funding Round
$24 M (USD), Series B
Apr 03, 2024
-
Investors
Agilent
& 4 more
-
Employee Count
28
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biofidelity
Biofidelity offers a comprehensive portfolio of products and services, including Aspyre®, Aspyre® Lung Reagents, and Enspyre®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for simple and reliable cancer biomarker detection.
Reagents supporting genomic testing for lung cancer applications.
Platform for end-to-end cancer patient journey monitoring.
Unlock access to complete
Unlock access to complete
Funding Insights of Biofidelity
Biofidelity has successfully raised a total of $59.91M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $24 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $24.0M
-
First Round
First Round
(03 Sep 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series B - Biofidelity | Valuation |
investors |
|
| Feb, 2022 | Amount | Series A - Biofidelity | Valuation | Octopus Ventures | |
| May, 2020 | Amount | Series A - Biofidelity | Valuation | BlueYard |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biofidelity
Biofidelity has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Agilent, Octopus Ventures and BlueYard Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and support for founders in technology and health sectors.
|
Founded Year | Domain | Location | |
|
BlueYard Capital is engaged in early-stage technology investments.
|
Founded Year | Domain | Location | |
|
Early-stage deeptech businesses are supported through venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biofidelity
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biofidelity
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biofidelity Comparisons
Competitors of Biofidelity
Biofidelity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biofidelity
Frequently Asked Questions about Biofidelity
When was Biofidelity founded?
Biofidelity was founded in 2002 and raised its 1st funding round 17 years after it was founded.
Where is Biofidelity located?
Biofidelity is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Who is the current CEO of Biofidelity?
Barney Balmforth is the current CEO of Biofidelity. They have also founded this company.
Is Biofidelity a funded company?
Biofidelity is a funded company, having raised a total of $59.91M across 4 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on Sep 03, 2019.
How many employees does Biofidelity have?
As of Dec 31, 2024, the latest employee count at Biofidelity is 28.
What does Biofidelity do?
Biofidelity was founded in 2002 in Cambridge, United Kingdom, within the biotechnology sector. Molecular diagnostic assays are developed using proprietary ASPYRE technology. Genetic panels are created for detecting specific cancers, including colorectal, melanoma, head and neck, liver and kidney, and breast. Operations focus on advancing diagnostic tools for oncology applications in a clinical setting.
Who are the top competitors of Biofidelity?
Biofidelity's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Biofidelity offer?
Biofidelity offers Aspyre®, Aspyre® Lung Reagents, and Enspyre®.
Who are Biofidelity's investors?
Biofidelity has 5 investors. Key investors include Agilent, Octopus Ventures, BlueYard Capital, Longwall Ventures, and SBI Investment.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.